Cardiac Implants Market Analysis

  • Report ID: 4111
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Cardiac Implants Market Segmentation:

By 2035, hospitals segment is expected to hold remarkable cardiac implants market share. The major factor attributed to the expansion of the segment is the presence of specially trained medical professionals for the usage of cardiac implants and a high number of cardiologists in hospitals across the globe. Also, the high number of hospitals in the world is considered to be another factor for the increased utilization rate of cardiac implants in hospital settings. For instance, the Organization for Economic Co-Operation and Development (OECD) stated that the number of hospitals in the United Kingdom increased from 1,882 in 2015 to 1921 in 2020, whereas, in the United States it rose from 5,564 in 2015 to 6,090 in 2019. In addition, the trust factor associated with the hospitals for proper diagnosis and treatment coupled with favorable policies present in the hospitals is also another factor that is considered to bring growth opportunities for noteworthy revenue generation of the segment. Patients suffering from chronic diseases, cardiovascular disorders, and other lifestyle illnesses often visit hospitals for treatment procedures which in turn is expected to boost segment growth in the next few years.

By 2035, arrhythmias segment is poised to hold substantial cardiac implants market share, as rising cases of arrhythmias and related diseases across the globe. For instance, in 2022, it was revealed that the prevalence of arrhythmias is found to be 2% to 5% in the world population. An unhealthy lifestyle and consumption of a poor diet is the reason behind the growth in the occurrence of arrhythmias.

Our in-depth analysis of the global cardiac implants market includes the following segments:

            By Product

          By Material

  • Alloys
  • Biological
  • Metals
  • Polymers

          By Procedure

  • Angioplasty
  • Open-Heart Surgery

             By Application

  • Acute Myocardial Infarction
  • Myocardial Ischemia
  • Arrhythmias
  • Congestive Heart Failures
  • Others

            By End-User

  • Cardiology Centers
  • Clinics
  • Hospitals
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of cardiac implants is evaluated at USD 48.29 billion.

The global cardiac implants market size was worth around USD 44.86 billion in 2025 and is set to register a CAGR of more than 8.5%, exceeding USD 101.43 billion revenue by 2035.

North America cardiac implants market will hold around 37% share by 2035, driven by the high frequency of heart diseases and robust healthcare infrastructure.

Key players in the market include Boston Scientific Corporation, BIOTRONIK SE & Co., KG, ZOLL Medical Corporation, Medtronic plc, LivaNova PLC, Abbott Laboratories, MEDICO S.R.L., Lepu Medica.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos